WO1984000003A1
(en)
|
1982-06-14 |
1984-01-05 |
Merrill Edward Wilson |
Process and apparatus for measuring blood viscosity directly and rapidly
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
AU727775B2
(en)
|
1996-01-17 |
2000-12-21 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
PT944648E
(pt)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk As |
Derivados do glp-1.
|
EP0958296B1
(en)
|
1996-12-31 |
2003-07-30 |
Dr. Reddy's Laboratories Ltd. |
Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
BR9810592A
(pt)
|
1997-07-16 |
2000-09-12 |
Novo Nordisk As |
Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
|
EP2574336A1
(en)
|
1998-02-02 |
2013-04-03 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
DE69917237T2
(de)
|
1998-03-12 |
2005-05-04 |
Teijin Ltd. |
Benzofurylpyron-derivate
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
BR9915961A
(pt)
|
1998-12-07 |
2001-08-21 |
Sod Conseils Rech Applic |
Análogos de glp-1
|
AUPP891299A0
(en)
|
1999-02-26 |
1999-03-25 |
Fujisawa Pharmaceutical Co., Ltd. |
New 6-membered cyclic compounds
|
EP1173438A1
(en)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
AU3957600A
(en)
|
1999-04-26 |
2000-11-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
PT1177176E
(pt)
|
1999-04-28 |
2006-08-31 |
Aventis Pharma Gmbh |
Derivados de acidos triarilicos como ligandos de receptores ppar.
|
SK15532001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s dvoma arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
AU4808300A
(en)
|
1999-04-30 |
2000-11-17 |
Neurogen Corporation |
9h-pyrimido(4,5-b)indole derivatives: crf1 specific ligands
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
DK1218341T3
(da)
|
1999-09-01 |
2005-12-12 |
Sanofi Aventis Deutschland |
Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
|
JP2003509430A
(ja)
|
1999-09-10 |
2003-03-11 |
ノボ ノルディスク アクティーゼルスカブ |
プロテインチロシンホスファターゼ(ptpアーゼ)のモジュレーター
|
WO2001019830A1
(en)
|
1999-09-10 |
2001-03-22 |
Novo Nordisk A/S |
MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
|
AU7476800A
(en)
|
1999-09-10 |
2001-04-10 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
EP1218336A2
(en)
|
1999-09-20 |
2002-07-03 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
RU2245878C2
(ru)
|
2000-03-23 |
2005-02-10 |
Солвей Фармасьютикалс Б.В. |
Производные 4,5-дигидро-1н-пиразола, обладающие cb1-антагонистической активностью
|
CA2407538C
(en)
|
2000-04-28 |
2007-01-09 |
Asahi Kasei Kabushiki Kaisha |
Novel bicyclic compounds
|
US6838465B2
(en)
|
2000-05-11 |
2005-01-04 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU2001264977B2
(en)
|
2000-05-30 |
2005-04-14 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
ES2238458T3
(es)
|
2000-06-16 |
2005-09-01 |
Smithkline Beecham Plc |
Piperidinas para uso como antagonistas de los receptores de orexina.
|
JP2004502423A
(ja)
|
2000-07-05 |
2004-01-29 |
シナプティック・ファーマスーティカル・コーポレーション |
ヒトメラニン濃縮ホルモン受容体(mch1)をコードするdna及びその使用
|
WO2002006245A1
(en)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmarceutical Corporation |
Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
|
CA2417638A1
(en)
|
2000-07-31 |
2002-02-07 |
Smithkline Beecham P.L.C. |
Carboxamide compounds and their use as antagonists of a human 11cby receptor
|
US6825220B2
(en)
|
2000-11-10 |
2004-11-30 |
Eli Lilly And Company |
3-Substituted oxindole β 3 agonists
|
US20030022891A1
(en)
|
2000-12-01 |
2003-01-30 |
Anandan Palani |
MCH antagonists and their use in the treatment of obesity
|
AU1609702A
(en)
|
2000-12-21 |
2002-07-01 |
Aventis Pharma Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
HUP0401073A2
(hu)
|
2000-12-21 |
2004-09-28 |
Aventis Pharma Deutschland Gmbh. |
Difenilazetidinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
PE20020856A1
(es)
|
2001-02-13 |
2002-11-11 |
Aventis Pharma Gmbh |
1,2,3,4-tetrahidronaftil aminas aciladas
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
PL363751A1
(en)
|
2001-03-22 |
2004-11-29 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
EP1392298B1
(en)
|
2001-05-04 |
2009-02-18 |
Amgen Inc. |
Fused heterocyclic compounds
|
EP1258247A1
(en)
|
2001-05-14 |
2002-11-20 |
Aventis Pharma Deutschland GmbH |
Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
IL159222A0
(en)
|
2001-06-28 |
2004-06-01 |
Algat Sherutey Gimur Teufati |
Method of anodizing of magnesium and magnesium alloys and producing conductive layers on an anodized surface
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
EP1425029A4
(en)
|
2001-08-10 |
2006-06-07 |
Palatin Technologies Inc |
PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
KR100915108B1
(ko)
|
2001-08-31 |
2009-09-03 |
사노피-아벤티스 도이칠란트 게엠베하 |
Ppar-활성화제로서의 디아릴사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물
|
CN1529595A
(zh)
|
2001-09-21 |
2004-09-15 |
������ҩ������˾ |
具有效cb1-拮抗活性的4,5-2氢-1h-吡唑衍生物
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
RU2299199C2
(ru)
|
2001-09-21 |
2007-05-20 |
Солвей Фармасьютикалс Б.В. |
Новые производные 4,5-дигидро-1h-пиразола, имеющие cb1-антагонистическую активность
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
UY27450A1
(es)
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
WO2003027069A1
(en)
|
2001-09-24 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Preparation and use of pyrrole derivatives for treating obesity
|
HUP0700124A2
(en)
|
2001-10-25 |
2007-06-28 |
Takeda Chemical Industries Ltd |
Quinoline compound
|
WO2003044009A1
(en)
|
2001-11-22 |
2003-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
IL160630A0
(en)
|
2001-11-22 |
2004-07-25 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
PL370111A1
(en)
|
2001-11-22 |
2005-05-16 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
AU2003207717B9
(en)
|
2002-02-01 |
2009-05-07 |
Merck & Co., Inc. |
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
ATE303178T1
(de)
|
2002-02-27 |
2005-09-15 |
Pfizer Prod Inc |
Acc-hemmer
|
AU2003215325B8
(en)
|
2002-03-05 |
2008-10-09 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
WO2003087037A1
(en)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
WO2003087044A2
(en)
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
WO2003087046A1
(en)
*
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel aminotetraline compounds for use in mch receptor related disorders
|
IL164249A0
(en)
|
2002-04-11 |
2005-12-18 |
Aventis Pharma Gmbh |
Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
JP4459629B2
(ja)
|
2002-04-12 |
2010-04-28 |
メルク エンド カムパニー インコーポレーテッド |
二環式アミド
|
US7229987B2
(en)
|
2002-05-13 |
2007-06-12 |
Eli Lilly And Company |
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
|
AU2003234929A1
(en)
|
2002-05-17 |
2003-12-02 |
Kyowa Hakko Kogyo Co., Ltd. |
Therapeutic agent for diabetes
|
TWI329111B
(en)
|
2002-05-24 |
2010-08-21 |
X Ceptor Therapeutics Inc |
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
|
US7595311B2
(en)
|
2002-05-24 |
2009-09-29 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
EP1375508A1
(en)
|
2002-06-27 |
2004-01-02 |
Aventis Pharma Deutschland GmbH |
N6-substituted adenosine analogues and their use as pharmaceutical agents
|
BR0305628A
(pt)
|
2002-07-09 |
2004-09-08 |
Palatin Technologies Inc |
Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
AU2003249937A1
(en)
|
2002-07-12 |
2004-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
|
CN1681763A
(zh)
|
2002-07-27 |
2005-10-12 |
阿斯特拉曾尼卡有限公司 |
化合物
|
KR100741231B1
(ko)
|
2002-07-29 |
2007-07-19 |
에프. 호프만-라 로슈 아게 |
신규 벤조다이옥솔
|
DE60322075D1
(de)
*
|
2002-07-30 |
2008-08-21 |
Merck & Co Inc |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
JP2005534713A
(ja)
|
2002-08-07 |
2005-11-17 |
三菱ウェルファーマ株式会社 |
ジヒドロピラゾロピリジン化合物
|
DE10237723A1
(de)
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
DE10238865A1
(de)
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US20040242572A1
(en)
*
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
BR0314098A
(pt)
|
2002-09-05 |
2005-07-19 |
Aventis Pharma Sa |
Derivados da aminoindazóis a tìtulo de medicamentos e composições farmacêuticas que os contêm
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
BR0314261A
(pt)
|
2002-09-12 |
2005-07-26 |
Hoffmann La Roche |
Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento
|
WO2004029204A2
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
MXPA05003632A
(es)
|
2002-10-11 |
2005-06-03 |
Astrazeneca Ab |
Derivados de piperidina 1, 4-disustituidos y su uso como inhibidores de 11-beta-hidroesteroide deshidrogenasa humana de tipo 1 (11betahsd1).
|
CA2502269C
(en)
|
2002-10-18 |
2009-12-22 |
Merck & Co., Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
EP1556373A1
(en)
|
2002-10-18 |
2005-07-27 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
AU2003274373A1
(en)
|
2002-10-24 |
2004-05-13 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
WO2004041274A1
(en)
|
2002-11-05 |
2004-05-21 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
WO2004041264A1
(en)
|
2002-11-07 |
2004-05-21 |
Astrazeneca Ab |
2-oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
MXPA05006728A
(es)
|
2002-12-19 |
2005-09-08 |
Merck & Co Inc |
Amidas sustituidas.
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
PT1585739E
(pt)
|
2003-01-06 |
2011-05-13 |
Lilly Co Eli |
Arilciclopropilacetamidas substitu?das como activadores da glucocinase
|
ES2295816T3
(es)
|
2003-01-14 |
2008-04-16 |
Arena Pharmaceuticals, Inc. |
Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
WO2004072066A1
(en)
|
2003-02-11 |
2004-08-26 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
RS20050572A
(en)
|
2003-02-13 |
2007-09-21 |
Sanofi-Aventis Deutschland Gmbh., |
Nitrogen-substituted hexahydropyrazino(1,2-a)pyrimidine – 4,7-dione derivatives, method for the production and use thereof as medicaments
|
KR20050111588A
(ko)
|
2003-02-13 |
2005-11-25 |
사노피-아벤티스 도이칠란트 게엠베하 |
치환된 헥사하이드로피라지노[1,2-a]피리미딘-4,7-디온유도체, 이의 제조방법 및 약제로서의 이의 용도
|
MXPA05008672A
(es)
|
2003-02-19 |
2005-10-18 |
Hoffmann La Roche |
Derivados de xantina sustituida con sulfonamida para el uso como inhibidores de fosfoenolpiruvato-carboxicinasa (pepck).
|
AR043434A1
(es)
|
2003-03-03 |
2005-07-27 |
Merck & Co Inc |
Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4. composiciones farmaceuticas y usos
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
WO2004087159A1
(en)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
WO2004085403A1
(en)
|
2003-03-26 |
2004-10-07 |
Actelion Pharmaceuticals Ltd |
Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
EP1615697A2
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof
|
JP2006522746A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
置換されたアミドの薬学的使用
|
DE602004025220D1
(de)
|
2003-04-11 |
2010-03-11 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen
|
MXPA05010859A
(es)
|
2003-04-11 |
2005-12-14 |
Smithkline Beecham Corp |
Antagonistas mchr1 heterociclicos.
|
EP1615637A1
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
JP4531696B2
(ja)
|
2003-04-25 |
2010-08-25 |
パナソニック株式会社 |
マルチメディア情報共有システム
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
US20060276452A1
(en)
|
2003-05-01 |
2006-12-07 |
Vernalis Research Limited |
Use of azetidinecarboxamide derivatives in therapy
|
WO2004096794A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
|
NZ543016A
(en)
|
2003-05-01 |
2009-03-31 |
Vernalis Res Ltd |
Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
|
JP4041153B2
(ja)
|
2003-05-07 |
2008-01-30 |
ファイザー・プロダクツ・インク |
カンナビノイド受容体リガンドとその使用
|
EP1626717A4
(en)
|
2003-05-09 |
2009-09-09 |
Merck & Co Inc |
BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
EP1631558A1
(en)
|
2003-05-21 |
2006-03-08 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
|
WO2004112793A1
(en)
|
2003-05-23 |
2004-12-29 |
Chiron Corporation |
Guanidino-substituted quinazolinone compounds as mc4-r agonists
|
WO2004106294A2
(en)
|
2003-05-29 |
2004-12-09 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
EP1636181A1
(en)
|
2003-06-11 |
2006-03-22 |
Merck & Co., Inc. |
Substituted 3-alkyl and 3-alkenyl azetidine derivatives
|
EP1654255B1
(en)
|
2003-06-13 |
2008-08-27 |
Janssen Pharmaceutica N.V. |
Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
|
GB0314057D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314049D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
EP1641779A1
(en)
|
2003-06-18 |
2006-04-05 |
AstraZeneca AB |
2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
|
CA2530024A1
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
GB0314261D0
(en)
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
CA2528785A1
(en)
|
2003-06-20 |
2005-01-06 |
Matthias Heinrich Nettekoven |
2-amidobenzothiazoles as cb1 receptor inverse agonists
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
CN100555588C
(zh)
|
2003-06-27 |
2009-10-28 |
日本电气株式会社 |
薄膜晶体管、薄膜晶体管基板、电子设备及多晶半导体薄膜的制造方法
|
US7029524B2
(en)
|
2003-06-27 |
2006-04-18 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
KR20060052792A
(ko)
|
2003-07-09 |
2006-05-19 |
포비스 메디-테크 인코포레이티드 |
신규 화합물 및 스테롤 및/또는 스탄올 및 콜레스테롤생합성 억제제를 포함하는 조성물 및 다양한 질병 및증상을 치료 또는 예방하기 위한 이들의 용도
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005007111A2
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
CN1826116A
(zh)
|
2003-07-22 |
2006-08-30 |
麦克公司 |
作为黑皮素-4受体激动剂的哌啶衍生物
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
US7659408B2
(en)
|
2003-08-07 |
2010-02-09 |
Merck Sharp & Dhome Corp. |
Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
WO2005021495A2
(en)
|
2003-08-25 |
2005-03-10 |
Microbia Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
WO2005021497A2
(en)
|
2003-08-28 |
2005-03-10 |
Microbia, Inc. |
Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
|
JP2007521322A
(ja)
|
2003-09-18 |
2007-08-02 |
メルク エンド カムパニー インコーポレーテッド |
置換スルホンアミド類
|
TWI336697B
(en)
|
2003-09-19 |
2011-02-01 |
Solvay Pharm Bv |
Thiazole derivatives as cannabinoid receptor modulators
|
WO2005027978A2
(en)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
WO2005030797A2
(en)
|
2003-09-30 |
2005-04-07 |
Novo Nordisk A/S |
Melanocortin receptor agonists
|
US20060247239A1
(en)
|
2003-10-01 |
2006-11-02 |
Hu Xiufeng E |
Melanin concentrating hormone antagonists
|
CA2540826A1
(en)
*
|
2003-10-01 |
2005-04-14 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
CN1870988A
(zh)
|
2003-10-30 |
2006-11-29 |
默克公司 |
作为抗高胆固醇血症药的2-氮杂环丁烷酮
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
US20050176738A1
(en)
|
2003-11-07 |
2005-08-11 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
ES2291951T3
(es)
|
2003-11-07 |
2008-03-01 |
F. Hoffmann-La Roche Ag |
Derivados de benzo (b) (1,4) dioxepina.
|
PT1682499E
(pt)
|
2003-11-10 |
2007-11-05 |
Microbia Inc |
4-biarilil-1-fenilazetidin-2-onas
|
WO2005047253A1
(en)
|
2003-11-12 |
2005-05-26 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
US7989634B2
(en)
|
2003-11-12 |
2011-08-02 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
CA2545601A1
(en)
|
2003-11-19 |
2005-06-09 |
Chiron Corporation |
Quinazolinone compounds with reduced bioaccumulation
|
CA2547430A1
(en)
|
2003-11-26 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
EP1538159A1
(en)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
WO2005060985A1
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2007514794A
(ja)
|
2003-12-19 |
2007-06-07 |
メルク エンド カムパニー インコーポレーテッド |
環式グアニジン、そのような化合物を含む組成、及び使用方法
|
KR20060103265A
(ko)
|
2003-12-19 |
2006-09-28 |
브리스톨-마이어스 스큅 컴퍼니 |
카나비노이드 수용체 조절제인 아자비시클릭 헤테로사이클
|
RU2006126122A
(ru)
|
2003-12-19 |
2008-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Азабициклические гетероциклы как модуляторы каннабиоидного рецептора
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
TW200528455A
(en)
|
2003-12-19 |
2005-09-01 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
US7365075B2
(en)
|
2003-12-22 |
2008-04-29 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
WO2005061452A1
(en)
|
2003-12-23 |
2005-07-07 |
Astrazeneca Ab |
Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
|
EP1699760B1
(en)
|
2003-12-23 |
2017-05-17 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
NZ547965A
(en)
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
JP2007517800A
(ja)
|
2004-01-06 |
2007-07-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
糖尿病および肥満を処置するためのグリコーゲンホスホリラーゼインヒビターとしての(3−オキソ−3,4−ジヒドロ−キノキサリン−2−イル−アミノ)−ベンズアミド誘導体および関連化合物
|
CA2553970A1
(en)
|
2004-01-28 |
2005-08-18 |
F. Hoffmann-La Roche Ag |
Spiro-benzodioxoles and their use as cb1 antagonists
|
AU2005209365A1
(en)
|
2004-01-31 |
2005-08-11 |
Sanofi-Aventis Deutschland Gmbh |
7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
EP1720847A1
(en)
|
2004-02-02 |
2006-11-15 |
Pfizer Products Incorporated |
Histamine-3 receptor modulators
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
AU2005212835A1
(en)
|
2004-02-17 |
2005-08-25 |
Laboratorios Del Dr. Esteve S.A. |
Substituted Azetidine compounds, their preparation and use as medicaments
|
CA2554686A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Compounds
|
DK1725536T3
(da)
|
2004-02-19 |
2009-02-16 |
Solvay Pharm Bv |
Imidazolin-derivater med CB1-antagonistisk aktivitet
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
US20090149463A1
(en)
|
2004-02-20 |
2009-06-11 |
Leifeng Cheng |
Therapeutic agents
|
WO2005080424A2
(en)
|
2004-02-23 |
2005-09-01 |
Rheoscience A/S |
Peptide yy analogues
|
EP1720861A2
(en)
|
2004-02-25 |
2006-11-15 |
Eli Lilly And Company |
Histamine h3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
AU2005219779B2
(en)
|
2004-03-04 |
2011-04-14 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
US20050250820A1
(en)
|
2004-03-08 |
2005-11-10 |
Amgen Inc. |
Therapeutic modulation of PPARgamma activity
|
US7504400B2
(en)
|
2004-03-10 |
2009-03-17 |
Janssen Pharmaceutica N.V. |
MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
CN1938286A
(zh)
|
2004-03-29 |
2007-03-28 |
默克公司 |
作为11-β-羟甾类脱氢酶-1抑制剂的二芳基三唑
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
JP2007531744A
(ja)
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6−アザインドール化合物
|
JPWO2005097738A1
(ja)
|
2004-04-06 |
2008-02-28 |
大日本住友製薬株式会社 |
新規スルホンアミド誘導体
|
WO2005097076A2
(en)
|
2004-04-09 |
2005-10-20 |
Smithkline Beecham Corporation |
Low dose pharmaceutical products
|
US20050256124A1
(en)
|
2004-04-15 |
2005-11-17 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
WO2005108370A1
(ja)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
ベンゼン化合物
|
JP2007537266A
(ja)
|
2004-05-12 |
2007-12-20 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
IκBキナーゼ阻害剤として実質的に純粋な2−{[2−(2−メチルアミノ−ピリミジン−4−イル)−1H−インドール−5−カルボニル]−アミノ}−3−(フェニルピリジン−2−イル−アミノ)−プロピオン酸
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
US20050288338A1
(en)
|
2004-06-24 |
2005-12-29 |
Wenqing Yao |
Amido compounds and their use as pharmaceuticals
|
MXPA06014415A
(es)
|
2004-06-24 |
2007-02-19 |
Shionogi & Co |
Compuestos de sulfonamida.
|
AU2005267331A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
EP1761521A1
(en)
|
2004-06-24 |
2007-03-14 |
Eli Lilly And Company |
Compounds and methods for treating dyslipidemia
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
DE602005008079D1
(de)
|
2004-07-28 |
2008-08-21 |
Hoffmann La Roche |
Aryl-pyridinderivate als 11-beta-hsd1-hemmer
|
FR2873693B1
(fr)
|
2004-07-29 |
2006-09-15 |
Sanofi Synthelabo |
Derives d'amino-tropane, leur preparation et leur application en therapeutique
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2575736A1
(en)
|
2004-08-06 |
2006-02-16 |
Merck & Co., Inc. |
Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
US7745491B2
(en)
|
2004-08-12 |
2010-06-29 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
EP1786422A2
(en)
|
2004-08-16 |
2007-05-23 |
Prosidion Limited |
Aryl urea derivatives for treating obesity
|
RU2007102288A
(ru)
|
2004-08-18 |
2008-09-27 |
Мебабазис Терапеутикс, Инк. (Us) |
Новые тиазольные ингибиторы фруктозо-1,6-бисфосфатазы
|
MY146435A
(en)
|
2004-08-30 |
2012-08-15 |
Janssen Pharmaceutica Nv |
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
WO2006029699A1
(en)
|
2004-09-11 |
2006-03-23 |
Sanofi-Aventis Deutschland Gmbh |
7-azaindoles and their use as ppar agonists
|
CA2581922A1
(en)
|
2004-09-29 |
2006-04-06 |
Kissei Pharmaceutical Co., Ltd. |
1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof
|
DK1797042T3
(da)
|
2004-09-29 |
2009-03-02 |
Hoffmann La Roche |
Indozolonderivater som 11B-HSD1-inhibitorer
|
EP1796669B1
(en)
|
2004-10-01 |
2010-09-22 |
Merck Sharp & Dohme Corp. |
Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
JP5107713B2
(ja)
|
2004-10-07 |
2012-12-26 |
ノヴォ ノルディスク アー/エス |
遅延性のエキセンディン−4化合物
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
EP1802623A1
(en)
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
WO2006044293A2
(en)
|
2004-10-12 |
2006-04-27 |
Pharmacopeia Drug Discovery, Inc. |
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
RU2007118932A
(ru)
|
2004-10-22 |
2008-11-27 |
Смитклайн Бичам Корпорейшн (US) |
Производные ксантина с активностью нм74а
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
ATE419848T1
(de)
|
2004-10-29 |
2009-01-15 |
Lilly Co Eli |
Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
|
US20090093463A1
(en)
|
2004-11-02 |
2009-04-09 |
Agouron Pharmaceuticals Inc. |
Novel compounds of substituted and unsubtituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
CA2587800C
(en)
|
2004-11-29 |
2012-06-12 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
WO2006059744A1
(ja)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
CN101137631A
(zh)
|
2004-12-03 |
2008-03-05 |
转化技术制药公司 |
杂芳族葡糖激酶激活剂
|
CA2589483C
(en)
|
2004-12-03 |
2013-10-29 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
EP1888544A2
(en)
|
2004-12-17 |
2008-02-20 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
BRPI0519566A2
(pt)
|
2004-12-18 |
2009-01-27 |
Bayer Healthcare Ag |
derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp
|
WO2006067443A1
(en)
|
2004-12-23 |
2006-06-29 |
Astrazeneca Ab |
Therapeutic agents
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
EP1833802A2
(en)
|
2004-12-23 |
2007-09-19 |
AstraZeneca AB |
1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
|
EP1838706A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor agonists
|
TW200635930A
(en)
|
2004-12-24 |
2006-10-16 |
Dainippon Sumitomo Pharma Co |
Bicyclic pyrrole derivatives
|
EP1838311A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
ES2644450T3
(es)
|
2004-12-31 |
2017-11-29 |
Dr. Reddy's Laboratories Ltd. |
Nuevos derivados de bencilamina como inhibidores de CETP
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
NZ555966A
(en)
|
2005-01-05 |
2011-03-31 |
Abbott Lab |
Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
US7956061B2
(en)
|
2005-01-19 |
2011-06-07 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
WO2006084176A2
(en)
|
2005-02-03 |
2006-08-10 |
Irm Llc |
Compounds and compositions as ppar modulators
|
EP1851197A2
(en)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
WO2006085685A1
(ja)
|
2005-02-09 |
2006-08-17 |
Takeda Pharmaceutical Company Limited |
ピラゾール化合物
|
SI1856090T1
(sl)
|
2005-02-11 |
2010-02-26 |
Lilly Co Eli |
Substituirani derivati tiofena kot antagonisti glukagonskega receptorja, priprava in terapevtske uporabe
|
GB0503056D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
GB0503053D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
EP1848699A1
(en)
|
2005-02-14 |
2007-10-31 |
Smithkline Beecham Corporation |
Anthranilic acid derivatives as hm74a receptor agonists
|
JP5020065B2
(ja)
|
2005-02-15 |
2012-09-05 |
キッセイ薬品工業株式会社 |
1−置換−7−(β−D−グリコピラノシルオキシ)(アザ)インドール化合物、及びそれを含有する医薬
|
MX2007009782A
(es)
|
2005-02-15 |
2007-08-22 |
Novo Nordisk As |
5-aminopiridin-2-ilesteres de acido 3,4-dihidro-1h-isoquinolin-2- carboxilico.
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
BRPI0607433A2
(pt)
|
2005-02-25 |
2009-09-08 |
Takeda Pharmaceutical |
composto ou um sal do mesmo, pró-droga, agente farmacêutico, inibidor de peptidase, uso de um composto ou de uma pró-droga do mesmo, e, métodos de prevenção ou tratamento de doenças, de inibição de peptidase em um mamìfero, e de produção de um composto
|
US20060229250A1
(en)
|
2005-03-09 |
2006-10-12 |
Jian Zhang |
Ghrelin associated peptide and its uses
|
KR100925307B1
(ko)
|
2005-03-09 |
2009-11-04 |
에프. 호프만-라 로슈 아게 |
항당뇨성 화합물로서 벤조티아졸, 티아졸로피리딘,벤조옥사졸 및 옥사졸로피리딘 유도체
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
BRPI0608653A2
(pt)
|
2005-04-01 |
2010-11-30 |
Lilly Co Eli |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou um sal do mesmo
|
DK1868999T3
(da)
|
2005-04-06 |
2009-08-17 |
Hoffmann La Roche |
Pyridin-3-carboxamidderivater som omvendte CB1-agonister
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
AU2006236939A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck Sharp & Dohme Corp. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
WO2006108842A1
(en)
|
2005-04-15 |
2006-10-19 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AU2006236387A1
(en)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Subtituted heteroaryl CB1 antagonists
|
MX2007013133A
(es)
|
2005-04-19 |
2008-03-14 |
Surface Logix Inc |
Inhibidores de la proteina microsomal de transferencia de trigliceridos de la secrecion de apo-b.
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
JP2008536909A
(ja)
|
2005-04-20 |
2008-09-11 |
ファイザー・プロダクツ・インク |
カンナビノイド受容体リガンドとしてのアシルアミノ二環複素芳香族化合物
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
EP1877373A2
(en)
|
2005-05-05 |
2008-01-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
JP2008539735A
(ja)
|
2005-05-06 |
2008-11-20 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
グルカゴン様ペプチド1(glp−1)受容体アンタゴニストおよびそれらの薬理学的使用方法
|
EP1879860A2
(en)
|
2005-05-10 |
2008-01-23 |
Microbia Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
AU2006244043A1
(en)
|
2005-05-11 |
2006-11-16 |
Microbia, Inc. |
Processes for production of phenolic 4-biphenylylazetidin-2-ones
|
ES2350852T3
(es)
|
2005-05-13 |
2011-01-27 |
Eli Lilly And Company |
Compuestos glp-1 pegilados.
|
AU2006247695B2
(en)
|
2005-05-17 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
EP1888066B1
(en)
|
2005-05-25 |
2012-01-11 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
BRPI0611415A2
(pt)
|
2005-05-25 |
2010-09-08 |
Microbia Inc |
ácidos fosfÈnicos de 4-(bifenilil)azetidin-2-ona e processo para a produção dos mesmos
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
KR100970294B1
(ko)
|
2005-06-08 |
2010-07-15 |
니뽄 다바코 산교 가부시키가이샤 |
복소환 화합물
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026809A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026808A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
CN101198338A
(zh)
|
2005-06-15 |
2008-06-11 |
默克公司 |
抗高胆固醇血化合物
|
WO2006134467A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
N-(pyridin-2-yl)-sulfonamide derivatives
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
WO2006133926A1
(en)
|
2005-06-17 |
2006-12-21 |
Carex Sa |
Pyrazole derivates as cannabinoid receptor modulators
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057072A1
(es)
|
2005-06-22 |
2007-11-14 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
KR100970055B1
(ko)
|
2005-06-22 |
2010-07-16 |
에프. 호프만-라 로슈 아게 |
6-(플루오로-벤조[1,3]디옥솔일)-모폴린-4-일-메탄온 및cb1 리간드로서 그의 용도
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
NZ564759A
(en)
|
2005-06-30 |
2011-08-26 |
Prosidion Ltd |
GPCR agonists
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
CA2613236A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
G-protein coupled receptor agonists
|
PT1904455E
(pt)
|
2005-07-05 |
2011-10-04 |
Hoffmann La Roche |
Derivados de piridazina
|
JP2009500377A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
ジシクロアルキルウレア型グルコキナーゼ活性化剤
|
ATE547396T1
(de)
|
2005-07-08 |
2012-03-15 |
Novo Nordisk As |
Dicycloalkylcarbamoyl-harnstoffe als glucokinase- aktivatoren
|
WO2007007688A1
(ja)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
3,5-ジアミノ-1,2,4-トリアゾール誘導体
|
NZ575513A
(en)
|
2005-07-09 |
2009-11-27 |
Astrazeneca Ab |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
EP2027113A1
(en)
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
JP4033409B1
(ja)
|
2005-07-11 |
2008-01-16 |
田辺三菱製薬株式会社 |
オキシム誘導体及びその製法
|
EP1905769B1
(en)
|
2005-07-13 |
2017-03-29 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
US7884210B2
(en)
|
2005-07-14 |
2011-02-08 |
Novo Nordisk A/S |
Ureido-thiazole glucokinase activators
|
EP1757587A1
(en)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
WO2007009705A1
(en)
|
2005-07-15 |
2007-01-25 |
Laboratorios Del Dr. Esteve, S.A. |
(rac)-n-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydr0-1h-pyrazole-3-carboxamide hydrates
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
WO2007009894A2
(en)
|
2005-07-18 |
2007-01-25 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
CA2614963C
(en)
|
2005-07-19 |
2014-10-07 |
Merck & Co., Inc. |
Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
|
ATE432259T1
(de)
|
2005-07-20 |
2009-06-15 |
Lilly Co Eli |
Pyridinderivate als dipeptedyl-peptidase-hemmer
|
AU2006271809B2
(en)
|
2005-07-21 |
2010-03-18 |
F. Hoffmann-La Roche Ag |
Pyrido [2 , 3-D] pyrimidine-2 , 4-diamine compounds as PTP1B inhibitors
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
JPWO2007013691A1
(ja)
|
2005-07-29 |
2009-02-12 |
武田薬品工業株式会社 |
スピロ環化合物
|
JP5084503B2
(ja)
|
2005-07-29 |
2012-11-28 |
武田薬品工業株式会社 |
シクロプロパンカルボン酸化合物
|
WO2007016460A2
(en)
|
2005-07-29 |
2007-02-08 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction by partial magnetic levitation
|
WO2007017124A1
(en)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
Amorphous phase of a substituted pyrazoline, its preparation and use as medicament
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
AU2006275568A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
CA2617654A1
(en)
|
2005-08-04 |
2007-02-08 |
Pfizer Limited |
Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
|
CN101282954A
(zh)
|
2005-08-08 |
2008-10-08 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
US20080306087A1
(en)
|
2005-08-08 |
2008-12-11 |
Astrazeneca Ab |
Therapeutic Agents
|
US20100160286A1
(en)
|
2005-08-09 |
2010-06-24 |
Astrazeneca Uk Limited Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
EP2272848B1
(en)
|
2005-08-10 |
2012-12-26 |
Glaxosmithkline LLC |
Xanthine derivatives as selective HM74A agonists
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
ATE430744T1
(de)
|
2005-08-18 |
2009-05-15 |
Hoffmann La Roche |
Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
|
EP1921917B1
(en)
|
2005-08-26 |
2012-03-21 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
US20090258862A1
(en)
|
2005-08-29 |
2009-10-15 |
Colletti Steven L |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
WO2007026215A1
(en)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
WO2007026761A1
(ja)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
チアゾール誘導体
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
MXPA05009633A
(es)
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
GB2429975A
(en)
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
CA2621949A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
JP2009508832A
(ja)
|
2005-09-16 |
2009-03-05 |
アストラゼネカ アクチボラグ |
グルコキナーゼ活性化剤としてのヘテロ二環式化合物
|
MX2008003634A
(es)
|
2005-09-16 |
2009-10-08 |
Arena Pharm Inc |
Moduladores del metabolismo y tratamiento de los trastornos metabolicos.
|
WO2007038943A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
BRPI0520563A2
(pt)
|
2005-09-21 |
2009-05-19 |
7Tm Pharma As |
agonistas de receptores y4 seletivos para intervenções terapêuticas
|
CA2621255A1
(en)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
CN101312725B
(zh)
|
2005-09-23 |
2012-01-11 |
詹森药业有限公司 |
六氢-环辛四烯并吡唑大麻素调节剂
|
WO2007038045A1
(en)
|
2005-09-23 |
2007-04-05 |
Janssen Pharmaceutica, N.V. |
Tetrahydro-indazolyl cannabinoid modulators
|
KR20080048520A
(ko)
|
2005-09-29 |
2008-06-02 |
사노피-아벤티스 |
페닐 그룹을 갖는, 페닐- 및 피리딜-1,2,4-옥사디아졸론유도체, 이의 제조 방법 및 약제로서의 이의 용도
|
JP4879988B2
(ja)
|
2005-09-29 |
2012-02-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
メラノコルチン−4受容体モジュレーターとしてのアシル化スピロピペリジン誘導体
|
CA2624031A1
(en)
|
2005-09-30 |
2007-04-12 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
JP4990783B2
(ja)
|
2005-09-30 |
2012-08-01 |
Msd株式会社 |
2−ヘテロアリール置換インドール誘導体
|
CA2624535A1
(en)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
EP1942904A4
(en)
|
2005-09-30 |
2009-11-18 |
Merck & Co Inc |
CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
WO2007047737A1
(en)
|
2005-10-17 |
2007-04-26 |
Acadia Pharmaceuticals Inc. |
Cb-1 modulating compounds and their use
|
DE102005049953A1
(de)
|
2005-10-19 |
2007-04-26 |
Sanofi-Aventis Deutschland Gmbh |
Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
CN103724335A
(zh)
|
2005-10-20 |
2014-04-16 |
默沙东公司 |
用作11β-羟基类固醇脱氢酶-1抑制剂的三唑衍生物
|
WO2007046548A1
(en)
|
2005-10-21 |
2007-04-26 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
|
WO2007049798A1
(ja)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
新規ベンゾオキサチイン誘導体
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
EP1948190A2
(en)
|
2005-11-01 |
2008-07-30 |
Transtech Pharma |
Pharmaceutical use of substituted amides
|
CA2628274A1
(en)
|
2005-11-01 |
2007-05-10 |
Array Biopharma Inc. |
Glucokinase activators
|
KR20080069189A
(ko)
|
2005-11-01 |
2008-07-25 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
WO2007053765A2
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
WO2007051845A1
(en)
|
2005-11-03 |
2007-05-10 |
Prosidion Ltd |
Tricyclo substituted amides
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
BRPI0618067A2
(pt)
|
2005-11-03 |
2011-08-16 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso e processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
JP2007131570A
(ja)
|
2005-11-09 |
2007-05-31 |
Mitsubishi Pharma Corp |
新規なアミノピロリジン誘導体
|
UA95613C2
(ru)
|
2005-11-09 |
2011-08-25 |
Уеллстат Терепьютикс Корпорейшн |
Соединения для лечения расстройсв метаболизма
|
AU2006312557B2
(en)
|
2005-11-10 |
2011-12-08 |
Msd K.K. |
Aza-substituted spiro derivative
|
SI1951661T1
(sl)
|
2005-11-17 |
2012-11-30 |
Lilly Co Eli |
Antagonisti glukagonskega receptorja priprava interapevtske uporabe
|
ES2393757T3
(es)
|
2005-11-17 |
2012-12-27 |
Eli Lilly & Company |
Antagonistas de receptor de glucagón, preparación y usos terapéuticos
|
WO2007057768A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Sulfonyl derivatives
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
BRPI0618692A2
(pt)
|
2005-11-18 |
2011-09-06 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os contém, métodos para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, uso dos compostos, tratamento ou prevenção de obesidade e de diabetes do tipo ii em um ser humano ou animal
|
GB0523609D0
(en)
|
2005-11-19 |
2005-12-28 |
Vernalis R&D Ltd |
Piperazine derivatives
|
RU2443689C2
(ru)
|
2005-11-21 |
2012-02-27 |
Сионоги Энд Ко., Лтд. |
ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ, ОБЛАДАЮЩИЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К 11β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЕ 1 ТИПА
|
JP5204662B2
(ja)
|
2005-11-22 |
2013-06-05 |
アムジエン・インコーポレーテツド |
11−β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
|
US8691856B2
(en)
|
2005-11-22 |
2014-04-08 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
DE102005055726A1
(de)
|
2005-11-23 |
2007-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US7807702B2
(en)
|
2005-11-23 |
2010-10-05 |
Eli Lilly And Company |
Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses
|
WO2007060992A1
(ja)
|
2005-11-25 |
2007-05-31 |
Kaneka Corporation |
メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
|
AR058199A1
(es)
|
2005-11-28 |
2008-01-23 |
Merck & Co Inc |
Derivados de 3- alquilazetidina sustituidos con heterociclos
|
WO2007064272A1
(en)
|
2005-11-29 |
2007-06-07 |
Astrazeneca Ab |
Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
|
WO2007063928A1
(ja)
|
2005-11-30 |
2007-06-07 |
Toray Industries, Inc. |
新規な非環状アミンカルボキシアミド誘導体及びその塩
|
DK1959951T3
(da)
|
2005-12-01 |
2010-03-01 |
Hoffmann La Roche |
Heteroaryl-substituerede piperidinderivater som L-CPT1-inhibitorer
|
CN1978445B
(zh)
|
2005-12-02 |
2010-09-01 |
中国科学院上海药物研究所 |
一种可用作人源腺苷单核苷酸激活蛋白激酶激活剂的化合物及其制备方法和应用
|
UA94724C2
(en)
|
2005-12-08 |
2011-06-10 |
Новартис Аг |
Thiadiazolidinone derivatives as antidiabetic agents
|
UA94921C2
(en)
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
US7579351B2
(en)
|
2005-12-09 |
2009-08-25 |
Hoffmann-La Roche Inc. |
Tricyclic amide derivatives
|
AU2006326564B2
(en)
|
2005-12-14 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
|
US7825122B2
(en)
|
2005-12-14 |
2010-11-02 |
Amgen Inc. |
Diaza heterocyclic sulfonamide derivatives and their uses
|
WO2007070796A1
(en)
|
2005-12-15 |
2007-06-21 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
JP2009519290A
(ja)
|
2005-12-15 |
2009-05-14 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピロロ[2,3−c]ピリジン誘導体
|
DE602006014305D1
(de)
|
2005-12-16 |
2010-06-24 |
Hoffmann La Roche |
Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
BRPI0620027A2
(pt)
|
2005-12-19 |
2011-10-25 |
Tufts College |
inibidores da protease soft e formas pró-soft
|
US20070244169A1
(en)
|
2005-12-20 |
2007-10-18 |
Jun Feng |
Glucokinase activators
|
WO2007071576A1
(en)
|
2005-12-21 |
2007-06-28 |
F. Hoffmann-La Roche Ag |
New salt and polymorph of dpp-iv inhibitor
|
MX2008008337A
(es)
|
2005-12-21 |
2008-09-03 |
Schering Corp |
Fenoxipiperidinas y sus analogos utiles como antagonistas de histamina h3.
|
CN103224477A
(zh)
|
2005-12-22 |
2013-07-31 |
高点制药有限责任公司 |
作为PPAR-δ活化剂的苯氧基乙酸
|
WO2007073117A1
(en)
|
2005-12-22 |
2007-06-28 |
Crystalgenomics, Inc. |
Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
|
BRPI0620643A2
(pt)
|
2005-12-23 |
2011-12-20 |
Novartis Ag |
compostos de heterocìclicos condensados úteis como inibidores de dpp-iv, formulações farmacêuticas, produtos e usos dos compostos
|
US20090156465A1
(en)
|
2005-12-30 |
2009-06-18 |
Sattigeri Jitendra A |
Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
CN100999517B
(zh)
|
2006-01-11 |
2010-12-15 |
北京摩力克科技有限公司 |
吡唑甲酰胺衍生物,药物组合物和其制备方法
|
WO2007087150A2
(en)
|
2006-01-13 |
2007-08-02 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
JP2009525954A
(ja)
|
2006-01-13 |
2009-07-16 |
シェーリング コーポレイション |
Cb1モジュレーターとしてのジアリールピペリジン
|
AU2007204426A1
(en)
|
2006-01-13 |
2007-07-19 |
F. Hoffmann-La Roche Ag |
Cyclohexyl piperazinyl methanone derivatives and their use as histamine H3 receptor modulators
|
CA2637565A1
(en)
|
2006-01-18 |
2007-07-26 |
Schering Corporation |
Cannibinoid receptor modulators
|
WO2007138485A2
(en)
|
2006-01-18 |
2007-12-06 |
Evolva Sa |
Ppar modulators
|
WO2007133820A2
(en)
|
2006-01-19 |
2007-11-22 |
Neurogen Corporation |
Diaryl triazolones as cb1 antagonists
|
BRPI0706654A2
(pt)
|
2006-01-20 |
2011-04-05 |
Smithkline Beecham Corp |
composição farmacêutica, método para tratar condições ou distìrbios em um mamìfero, uso de um composto, e, composto
|
KR20070077468A
(ko)
|
2006-01-23 |
2007-07-26 |
크리스탈지노믹스(주) |
단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물
|
AU2007206997B2
(en)
|
2006-01-23 |
2011-11-24 |
F. Hoffmann-La Roche Ag |
Cyclohexyl sulfonamide derivatives having H3 receptor activity
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
EP1978804B1
(en)
|
2006-01-25 |
2014-07-30 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
CN101007804B
(zh)
|
2006-01-25 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
1,3-苯并间二氧杂环戊烯-2,2-二羧酸衍生物、其制备方法和医疗用途
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
ATE539748T1
(de)
|
2006-01-27 |
2012-01-15 |
Array Biopharma Inc |
Glucokinaseaktivatoren
|
WO2007086080A2
(en)
|
2006-01-30 |
2007-08-02 |
Glenmark Pharmaceuticals Limited |
NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
PT1979355E
(pt)
|
2006-01-30 |
2010-10-27 |
Irm Llc |
Derivados de espiroimidazole como moduladores de ppar
|
EP1979347A2
(en)
|
2006-01-30 |
2008-10-15 |
Irm Llc |
Polycyclic 1,2,3,4-tetrahydro-isoquinoline derivatives and compositions comprising them as ppar modulators
|
CA2627644A1
(en)
|
2006-01-30 |
2007-08-09 |
Irm Llc |
Compounds and compositions as ppar modulators
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
JP2009525333A
(ja)
|
2006-01-31 |
2009-07-09 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
UY30117A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compuesto amina trisustituido
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
EP1816125A1
(en)
|
2006-02-02 |
2007-08-08 |
Ranbaxy Laboratories, Ltd. |
Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
CN101374834B
(zh)
|
2006-02-03 |
2011-12-14 |
伊莱利利公司 |
用于调节fxr的化合物和方法
|
EP2013216A2
(en)
|
2006-02-07 |
2009-01-14 |
AstraZeneca AB |
Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
|
AU2007212534A1
(en)
|
2006-02-07 |
2007-08-16 |
Merck Sharp & Dohme Corp. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
US7572823B2
(en)
|
2006-02-07 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Heteroaryl carboxamide compounds
|
US7678818B2
(en)
|
2006-02-07 |
2010-03-16 |
Hoffmann-La Roche Inc. |
Anthranilamide and 2-amino-heteroarene-carboxamide compounds
|
US7745477B2
(en)
|
2006-02-07 |
2010-06-29 |
Hoffman-La Roche Inc. |
Heteroaryl and benzyl amide compounds
|
US7691876B2
(en)
|
2006-02-07 |
2010-04-06 |
Hoffmann-La Roche Inc. |
Heterobicyclic amide compounds
|
CN101379034B
(zh)
|
2006-02-07 |
2011-12-28 |
弗·哈夫曼-拉罗切有限公司 |
作为cetp抑制剂的苯甲酰胺和杂芳烃衍生物
|
RU2008132333A
(ru)
|
2006-02-07 |
2010-03-20 |
Вайет (Us) |
Ингибиторы 11-бета hsd1
|
WO2007094962A2
(en)
|
2006-02-09 |
2007-08-23 |
Athersys, Inc. |
Pyrazoles for the treatment of obesity and other cns disorders
|
US7641803B2
(en)
|
2006-02-10 |
2010-01-05 |
Gunderboom, Inc. |
Filter cartridges for fluid intake systems
|
WO2007095462A2
(en)
|
2006-02-13 |
2007-08-23 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
WO2007095513A1
(en)
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
|
AU2007215207A1
(en)
|
2006-02-14 |
2007-08-23 |
Intercept Pharmaceuticals, Inc. |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
|
DE102006006648A1
(de)
|
2006-02-14 |
2007-08-23 |
Merck Patent Gmbh |
Mandelsäurehydrazide
|
JP5291471B2
(ja)
|
2006-02-15 |
2013-09-18 |
アボット・ラボラトリーズ |
新規なアセチル−CoAカルボキシラーゼ(ACC)阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
|
EP1986652B1
(en)
|
2006-02-15 |
2013-03-20 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
CN101384568B
(zh)
|
2006-02-15 |
2012-12-12 |
雅培制药有限公司 |
乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
|
KR20080102395A
(ko)
|
2006-02-15 |
2008-11-25 |
베링거 인겔하임 인터내셔날 게엠베하 |
글루코피라노실-치환된 벤조니트릴 유도체, 당해 화합물을 함유하는 약제학적 조성물, 이들의 용도 및 이들의 제조방법
|
ITRM20060090A1
(it)
|
2006-02-22 |
2007-08-23 |
Sigma Tau Ind Farmaceuti |
Nuovi composti inibitori cpt a livello del snc come farmaci antidiabetici e o antiobesita
|
WO2007096186A1
(en)
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
EA200801738A1
(ru)
|
2006-02-23 |
2008-12-30 |
Пфайзер Лимитед |
Пиперидиноилпирролидиновые агонисты меланокортинового рецептора 4 типа
|
WO2007100833A2
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
US7728031B2
(en)
|
2006-02-24 |
2010-06-01 |
Abbott Laboratories |
Octahydro-pyrrolo[3,4-b]pyrrole derivatives
|
US20080038278A1
(en)
|
2006-02-24 |
2008-02-14 |
Jingsong Cao |
GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase
|
ES2327187T3
(es)
|
2006-02-27 |
2009-10-26 |
Cadila Healthcare Limited |
Acidos 1,3-dioxano carboxilicos.
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
ATE530066T1
(de)
|
2006-02-28 |
2011-11-15 |
Wellstat Therapeutics Corp |
Verbindungen zur behandlung von stoffwechselstörungen
|
WO2007099385A1
(en)
|
2006-03-01 |
2007-09-07 |
Glenmark Pharmaceuticals S.A. |
Dipeptidyl peptidase iv inhibitor compounds and compositions
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
JP2007230909A
(ja)
|
2006-03-01 |
2007-09-13 |
Univ Of Tokyo |
置換イソキサゾール誘導体
|
WO2007100027A1
(ja)
|
2006-03-02 |
2007-09-07 |
Daiichi Sankyo Company, Limited |
光学活性なチアゾリジンジオン誘導体
|
TW200808807A
(en)
|
2006-03-02 |
2008-02-16 |
Incyte Corp |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
US20090264473A1
(en)
|
2006-03-03 |
2009-10-22 |
Zhiguo Jake Song |
Novel Crystalline Forms of Antidiabetic Compounds
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
US20070270492A1
(en)
|
2006-03-06 |
2007-11-22 |
Avestha Gengraine Technologies Pvt. Ltd. |
Nananoic acid derivatives as dipeptidyl peptidase inhibitors
|
US20080051452A1
(en)
|
2006-03-06 |
2008-02-28 |
Avestha Gengraine Technologies Pvt. Ltd. |
Hexanoic acid derivatives as dipeptidyl peptidase inhibitors
|
TW200800979A
(en)
|
2006-03-07 |
2008-01-01 |
Lundbeck & Co As H |
Halogenated sulfonamide derivatives
|
JP2009132620A
(ja)
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
US8034822B2
(en)
|
2006-03-08 |
2011-10-11 |
Takeda San Diego, Inc. |
Glucokinase activators
|
KR20080107466A
(ko)
|
2006-03-09 |
2008-12-10 |
파마코페이아, 인코포레이티드 |
대사 장애 치료용 8-헤테로아릴퓨린 mnk2 억제제
|
EP1999098A2
(en)
|
2006-03-09 |
2008-12-10 |
High Point Pharmaceuticals, LLC |
Compounds that modulate ppar activity, their preparation and use
|
WO2007105650A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ajinomoto Co., Inc. |
4-ヒドロキシイソロイシン誘導体および同誘導体の製造方法
|
EP1998620B1
(en)
|
2006-03-10 |
2011-01-12 |
Neurogen Corporation |
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
|
AU2007226673A1
(en)
|
2006-03-10 |
2007-09-20 |
Jenrin Discovery |
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
|
JP2009539762A
(ja)
|
2006-03-13 |
2009-11-19 |
ファイザー・プロダクツ・インク |
H3受容体のテトラリン拮抗薬
|
MX2008011615A
(es)
|
2006-03-14 |
2008-09-22 |
Amgen Inc |
Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
|
CN101400698A
(zh)
|
2006-03-15 |
2009-04-01 |
诺沃-诺迪斯克有限公司 |
胰岛淀粉样多肽衍生物
|
EP1834641A1
(en)
|
2006-03-16 |
2007-09-19 |
Sanofi-Aventis |
Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
|
AU2007225680A1
(en)
|
2006-03-16 |
2007-09-20 |
Astellas Pharma Inc. |
Triazole derivative or salt thereof
|
JP5243696B2
(ja)
|
2006-03-17 |
2013-07-24 |
田辺三菱製薬株式会社 |
ベンゼン誘導体
|
DE102006012548A1
(de)
|
2006-03-18 |
2007-09-20 |
Bayer Healthcare Ag |
Substituierte Chromanol-Derivate und ihre Verwendung
|
EP2007722A1
(en)
|
2006-03-21 |
2008-12-31 |
High Point Pharmaceuticals, LLC |
Adamantane derivatives for the treatment of the metabolic syndrome
|
HUE026011T2
(en)
|
2006-03-22 |
2016-05-30 |
Hoffmann La Roche |
Pyrazoles as 11-beta-HSD-1
|
CA2645639A1
(en)
|
2006-03-23 |
2007-10-04 |
Merck & Co. Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
JP2009530393A
(ja)
|
2006-03-23 |
2009-08-27 |
イノテック ファーマシューティカルズ コーポレイション |
プリン化合物およびその使用方法
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
AU2007231594A1
(en)
|
2006-03-23 |
2007-10-04 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
FR2898892A1
(fr)
|
2006-03-24 |
2007-09-28 |
Genfit Sa |
Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
|
FR2898894B1
(fr)
|
2006-03-24 |
2008-06-06 |
Genfit Sa |
Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
|
ES2536547T3
(es)
|
2006-03-24 |
2015-05-26 |
Array Biopharma, Inc. |
Análogos de 2-aminopiridina como activadores de glucoquinasa
|
US8012957B2
(en)
|
2006-03-27 |
2011-09-06 |
Janssen Pharmaceutica Nv |
Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators
|
US20070254911A1
(en)
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
JP2007291075A
(ja)
|
2006-03-27 |
2007-11-08 |
Sankyo Co Ltd |
新規化合物ステレニン及びその製造方法
|
DE102006014685A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
|
US8394842B2
(en)
|
2006-03-28 |
2013-03-12 |
High Point Pharmaceuticals, Llc |
Benzothiazoles having histamine H3 receptor activity
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
TW200806669A
(en)
|
2006-03-28 |
2008-02-01 |
Merck & Co Inc |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
DE102006014688A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
JP2009531364A
(ja)
|
2006-03-28 |
2009-09-03 |
ノバルティス アクチエンゲゼルシャフト |
アミド誘導体およびgタンパク質関連疾患の処置のためのそれらの使用
|
US8685961B2
(en)
|
2006-03-29 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Diazepan orexin receptor antagonists
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
GB0606429D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
RU2424242C2
(ru)
|
2006-03-30 |
2011-07-20 |
Айрм Ллк |
Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
|
DE602007008545D1
(de)
|
2006-03-31 |
2010-09-30 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyridine und pyrazine als modulatoren des histamin-h4-rezeptors
|
US8084448B2
(en)
|
2006-03-31 |
2011-12-27 |
Novartis Ag |
Organic compounds
|
BRPI0710110A2
(pt)
|
2006-03-31 |
2011-08-02 |
Novartis Ag |
compostos orgánicos
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
WO2007114532A1
(en)
|
2006-04-03 |
2007-10-11 |
Industry-Academic Cooperation Foundation Gyeongsang National University |
Novel chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
|
JP2009532454A
(ja)
|
2006-04-03 |
2009-09-10 |
マトリックス ラボラトリーズ リミテッド |
新規ジペプチジルペプチダーゼiv阻害因子およびその調製方法、ならび該阻害因子を含む医薬組成物
|
CN101050194B
(zh)
|
2006-04-05 |
2013-08-21 |
上海恒瑞医药有限公司 |
双环辛烷类衍生物、其制备方法及其在医药上的用途
|
BRPI0710839A2
(pt)
|
2006-04-06 |
2011-08-23 |
Prosidion Ltd |
agonistas heterocìclicos de gpcr
|
JP5302883B2
(ja)
|
2006-04-07 |
2013-10-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
医薬組成物用のmnk1/mnk2阻害活性を有するチエノピリミジン
|
CN101448782A
(zh)
|
2006-04-07 |
2009-06-03 |
高点制药有限责任公司 |
对1型11β-羟基甾体脱氢酶具有活性的化合物
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
EP1842846A1
(en)
|
2006-04-07 |
2007-10-10 |
Santhera Pharmaceuticals (Schweiz) AG |
Phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
US20100029716A1
(en)
|
2006-04-10 |
2010-02-04 |
Concert Pharmaceuticals, Inc. |
Novel 1,2,3,4- tetrahydroquinoline derivatives
|
AU2007236115A1
(en)
|
2006-04-11 |
2007-10-18 |
Novartis Ag |
Organic compounds
|
EP2010512A4
(en)
|
2006-04-11 |
2010-02-24 |
Merck & Co Inc |
NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
|
EP2007717A1
(en)
|
2006-04-11 |
2008-12-31 |
Actelion Pharmaceuticals Ltd. |
Novel sulfonamide compounds
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
CN101460491A
(zh)
|
2006-04-12 |
2009-06-17 |
惠氏公司 |
苯胺基嘧啶苯基和苯并噻吩类似物
|
BRPI0709984A2
(pt)
|
2006-04-12 |
2011-08-02 |
Probiodrug Ag |
inibidores de enzima
|
KR20090024115A
(ko)
|
2006-04-12 |
2009-03-06 |
에프. 호프만-라 로슈 아게 |
5-아미도-2-카복스아마이드 인돌
|
CA2648440A1
(en)
|
2006-04-13 |
2007-10-25 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. . |
Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof
|
FR2899899A1
(fr)
|
2006-04-14 |
2007-10-19 |
Sanofi Aventis Sa |
Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique
|
WO2007119833A1
(ja)
|
2006-04-14 |
2007-10-25 |
Takeda Pharmaceutical Company Limited |
含窒素複素環化合物
|
WO2007119837A1
(ja)
|
2006-04-14 |
2007-10-25 |
Ajinomoto Co., Inc. |
リパーゼ阻害剤
|
JP2007284090A
(ja)
|
2006-04-14 |
2007-11-01 |
Dic Plastics Inc |
蓋体の係止構造および容器
|
PE20080188A1
(es)
|
2006-04-18 |
2008-03-10 |
Janssen Pharmaceutica Nv |
Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol
|
BRPI0710266B8
(pt)
|
2006-04-18 |
2021-05-25 |
Nippon Chemiphar Co |
composto, medicamento, e, uso de um composto
|
WO2007120102A1
(en)
|
2006-04-19 |
2007-10-25 |
Astrazeneca Ab |
New substituted oxindole derivatives
|
ES2487967T3
(es)
|
2006-04-20 |
2014-08-25 |
Pfizer Products Inc. |
Compuestos amido heterocíclicos condensados con fenilo para la prevención y el tratamiento de enfermedades mediadas por la glucoquinasa
|
WO2007122970A1
(ja)
|
2006-04-20 |
2007-11-01 |
Osaka University |
核内受容体に結合するリガンド
|
MX2008013304A
(es)
|
2006-04-20 |
2008-10-27 |
Amgen Inc |
Compuestos de peptido 1 tipo glucagon.
|
GB0607954D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607953D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
US20070254952A1
(en)
|
2006-04-21 |
2007-11-01 |
Yuguang Wang |
Cannabinoid receptor modulators
|
GB0607951D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
CA2646678C
(en)
|
2006-04-21 |
2014-02-11 |
Eli Lilly And Company |
Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
JP5265521B2
(ja)
|
2006-04-21 |
2013-08-14 |
イーライ リリー アンド カンパニー |
11−β−ヒドロキシステロイドデヒドロゲナーゼ1阻害剤としてのビフェニルアミドラクタム誘導体
|
EA015675B1
(ru)
|
2006-04-21 |
2011-10-31 |
Эли Лилли Энд Компани |
Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
|
ATE473210T1
(de)
|
2006-04-24 |
2010-07-15 |
Lilly Co Eli |
Substituierte pyrrolidinone als hemmer von 11- beta-hydroxysteroiddehydrogenase 1
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
DK2049475T3
(da)
|
2006-04-24 |
2012-03-05 |
Lilly Co Eli |
Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1
|
WO2007122634A2
(en)
|
2006-04-24 |
2007-11-01 |
Jubilant Biosys Limited |
Pyrimidinediones as tyrosine kinase inhibitors
|
EA015106B1
(ru)
|
2006-04-24 |
2011-06-30 |
Эли Лилли Энд Компани |
Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1
|
EA015499B1
(ru)
|
2006-04-25 |
2011-08-30 |
Эли Лилли Энд Компани |
Ингибиторы 11-бета-гидроксистероид дегидрогеназы типа 1
|
BRPI0710875A2
(pt)
|
2006-04-25 |
2012-01-10 |
Lilly Co Eli |
composto inibidor de 11-beta-hidroxiesteróide desidrogenase 1, composição farmacêutica e intermediário para preparar o dito composto
|
EP2021337B1
(en)
|
2006-04-25 |
2010-01-13 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
US7659281B2
(en)
|
2006-04-25 |
2010-02-09 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors
|
WO2007122411A1
(en)
|
2006-04-26 |
2007-11-01 |
Astrazeneca Ab |
Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
|
WO2007122591A2
(en)
|
2006-04-26 |
2007-11-01 |
Actelion Pharmaceuticals Ltd |
Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
|
WO2007121687A1
(fr)
|
2006-04-26 |
2007-11-01 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China |
Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments
|
AR060623A1
(es)
|
2006-04-27 |
2008-07-02 |
Astrazeneca Ab |
Compuestos derivados de 2-azetidinona y un metodo de preparacion
|
WO2007126043A1
(ja)
|
2006-04-27 |
2007-11-08 |
Mitsubishi Tanabe Pharma Corporation |
チアゾール環を含むカルボン酸誘導体の医薬用途
|
US20070254863A1
(en)
|
2006-04-27 |
2007-11-01 |
Jochen Antel |
Use of CBx cannabinoid receptor modulators as potassium channel modulators
|
EP1849785A1
(en)
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
EP2019823B1
(en)
|
2006-04-28 |
2010-11-24 |
TransTech Pharma, Inc. |
Benzamide glucokinase activators
|
JP4528901B2
(ja)
|
2006-04-28 |
2010-08-25 |
塩野義製薬株式会社 |
Npyy5受容体拮抗作用を有するアミン誘導体
|
WO2007125103A2
(en)
|
2006-04-28 |
2007-11-08 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
PT2049513E
(pt)
|
2006-04-28 |
2012-03-20 |
Lilly Co Eli |
Pirrolidinonas substituídas com piperidinilo como inibidores de 11-beta-hidroxiesteróide desidrogenase i
|
US20070293529A1
(en)
|
2006-05-01 |
2007-12-20 |
Yun-Long Li |
Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
|
JP2009167104A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
フェニル5−チオグリコシド化合物
|
EP1854806A1
(en)
|
2006-05-02 |
2007-11-14 |
MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Thioglycosides as pharmaceutically active agents
|
JP2009167103A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
ピラゾリル5−チオグリコシド化合物
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
JP5323684B2
(ja)
|
2006-05-04 |
2013-10-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
多形体
|
AU2007257093A1
(en)
|
2006-05-05 |
2007-12-13 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of PCSK9
|
ES2389569T3
(es)
|
2006-05-05 |
2012-10-29 |
Jenrin Discovery |
Antagonistas/agonistas inversos de receptores de cannabinoides
|
WO2007128801A1
(en)
|
2006-05-08 |
2007-11-15 |
Novartis Ag |
Combination of organic compounds
|
US20080247964A1
(en)
|
2006-05-08 |
2008-10-09 |
Yuelian Xu |
Substituted azaspiro derivatives
|
WO2007128815A1
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
AU2007247109B2
(en)
|
2006-05-09 |
2012-03-15 |
Novo Nordisk A/S |
Insulin derivative
|
KR101172120B1
(ko)
|
2006-05-10 |
2012-08-10 |
노파르티스 아게 |
Cetp 억제제로서의 바이시클릭 유도체
|
WO2007133637A2
(en)
|
2006-05-10 |
2007-11-22 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
WO2007129188A1
(en)
|
2006-05-10 |
2007-11-15 |
Pfizer Japan Inc. |
Cyclopropanecarboxamide compound
|
JP2009536953A
(ja)
|
2006-05-11 |
2009-10-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Cetp阻害剤としての1,2,3,4−テトラヒドロ−キノリン誘導体
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CN101421248A
(zh)
|
2006-05-11 |
2009-04-29 |
塞诺菲-安万特股份有限公司 |
4,5-二苯基-嘧啶基取代的羧酸、其生产方法及其作为药物的用途
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
RU2008148600A
(ru)
|
2006-05-11 |
2010-06-20 |
Новартис АГ (CH) |
Производные бензиламина в качестве ингибиторов сетр
|
US7749995B2
(en)
|
2006-05-11 |
2010-07-06 |
Janssen Pharmaceutica Nv |
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
|
JP2009537523A
(ja)
|
2006-05-15 |
2009-10-29 |
メルク エンド カムパニー インコーポレーテッド |
三級アルコールのプロドラッグ
|
US7851468B2
(en)
|
2006-05-15 |
2010-12-14 |
Cephalon, Inc. |
Substituted pyrazolo[3,4-d]pyrimidines
|
EP2021327B1
(en)
|
2006-05-15 |
2012-04-04 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
TW200812588A
(en)
|
2006-05-15 |
2008-03-16 |
Neurogen Corp |
CRF1 receptor ligands comprising heteroaryl fused bicycles
|
AU2007254357B2
(en)
|
2006-05-16 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
US7432255B2
(en)
|
2006-05-16 |
2008-10-07 |
Hoffmann-La Roche Inc. |
1H-indol-5-yl-piperazin-1-yl-methanone derivatives
|
JP2009537525A
(ja)
|
2006-05-16 |
2009-10-29 |
メルク エンド カムパニー インコーポレーテッド |
グルカゴン受容体アンタゴニスト化合物、このような化合物を含む組成物及び使用方法
|
US7838544B2
(en)
|
2006-05-17 |
2010-11-23 |
Incyte Corporation |
Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same
|
EP2027132B1
(en)
|
2006-05-18 |
2010-09-15 |
F. Hoffmann-La Roche AG |
Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
|
WO2007136607A2
(en)
|
2006-05-18 |
2007-11-29 |
Merck & Co., Inc. |
Substituted esters as cannabinoid-1 receptor modulators
|
EP2019673A4
(en)
|
2006-05-18 |
2010-06-16 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
|
ATE533744T1
(de)
|
2006-05-19 |
2011-12-15 |
Wyeth Llc |
N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten
|
AU2007252432B2
(en)
|
2006-05-19 |
2011-11-17 |
Taisho Pharmaceutical Co., Ltd. |
C-phenyl glycitol compound
|
WO2007135111A1
(en)
|
2006-05-23 |
2007-11-29 |
High Point Pharmaceuticals, Llc |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
|
CN101448836B
(zh)
|
2006-05-23 |
2011-12-14 |
霍夫曼-拉罗奇有限公司 |
吡啶并嘧啶酮衍生物
|
WO2007135427A1
(en)
|
2006-05-23 |
2007-11-29 |
Astrazeneca Ab |
1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
|
EP2019679B1
(en)
|
2006-05-23 |
2018-06-20 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
DK2029547T3
(da)
|
2006-05-24 |
2010-07-26 |
Lilly Co Eli |
FXR-agonister
|
AU2007267692B2
(en)
|
2006-05-24 |
2012-06-14 |
Eli Lilly And Company |
Compounds and methods for modulating FXR
|
JP5105297B2
(ja)
|
2006-05-25 |
2012-12-26 |
味の素株式会社 |
Ppar活性調節剤
|
JP2009538323A
(ja)
|
2006-05-26 |
2009-11-05 |
ノバルティス アクチエンゲゼルシャフト |
アルドステロン合成酵素および/または11β−ヒドロキシラーゼ阻害剤
|
US20100292266A1
(en)
|
2006-05-26 |
2010-11-18 |
Richard Apodaca |
Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
|
MX2008015031A
(es)
|
2006-05-26 |
2008-12-05 |
Nestec Sa |
Metodos de uso y composiciones nutritivas de extracto de touchi.
|
TW200806625A
(en)
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
EP2079732B9
(en)
|
2006-05-29 |
2012-03-21 |
High Point Pharmaceuticals, LLC |
3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
|
WO2007137955A1
(en)
|
2006-05-30 |
2007-12-06 |
F. Hoffmann-La Roche Ag |
Piperidinyl pyrimidine derivatives
|
MX2008015365A
(es)
|
2006-05-30 |
2008-12-16 |
Janssen Pharmaceutica Nv |
Compuestos de piridil amida sustituidos como moduladores del receptor h3 de la histamina.
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
WO2007140385A2
(en)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Thiazole compounds as cannabinoid receptor ligands and uses thereof
|
CA2647598A1
(en)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands and uses thereof
|
JP5386350B2
(ja)
|
2006-05-31 |
2014-01-15 |
タケダ カリフォルニア インコーポレイテッド |
グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
|
CA2650622A1
(en)
|
2006-05-31 |
2007-12-06 |
Solvay Pharmaceuticals B.V. |
Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
|
KR101156367B1
(ko)
|
2006-06-01 |
2012-06-13 |
에프. 호프만-라 로슈 아게 |
티아졸 유도체
|
WO2007143164A1
(en)
|
2006-06-02 |
2007-12-13 |
San Diego State University Research Foundation |
Compositions and methods for ameliorating hyperlipidemia
|
JP2009190971A
(ja)
|
2006-06-06 |
2009-08-27 |
Mitsubishi Tanabe Pharma Corp |
2−シアノピロリジン誘導体
|
FR2901792A1
(fr)
|
2006-06-06 |
2007-12-07 |
Negma Lerads Soc Par Actions S |
DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
|
AU2007259143A1
(en)
|
2006-06-08 |
2007-12-21 |
Amgen Inc. |
Benzamide derivatives and uses related thereto
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
US20070287674A1
(en)
|
2006-06-08 |
2007-12-13 |
Hej Research Institute Of Chemistry |
New treatment of diabetes mellitus
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
MX2008015454A
(es)
|
2006-06-09 |
2009-01-30 |
Action Pharma As |
Derivados de fenil-pirrol-aminoguanidina.
|
WO2007146761A2
(en)
|
2006-06-12 |
2007-12-21 |
Neurogen Corporation |
Diaryl pyrimidinones and related compounds
|
WO2008035359A2
(en)
|
2006-06-12 |
2008-03-27 |
Cadila Healthcare Limited |
Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
|
US20090306048A1
(en)
|
2006-06-16 |
2009-12-10 |
John Paul Kilburn |
Pharmaceutical use of substituted piperidine carboxamides
|
US7629346B2
(en)
|
2006-06-19 |
2009-12-08 |
Hoffmann-La Roche Inc. |
Pyrazinecarboxamide derivatives as CB1 antagonists
|
US20100048714A1
(en)
|
2006-06-19 |
2010-02-25 |
University Of Utah Research Foundation |
Methods and Compositions Related to Inhibition of Ceramide Synthesis
|
JP2009541283A
(ja)
|
2006-06-20 |
2009-11-26 |
アストラゼネカ アクチボラグ |
治療薬
|
CN101472896A
(zh)
|
2006-06-20 |
2009-07-01 |
阿斯利康(瑞典)有限公司 |
治疗药剂
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
BRPI0713619A2
(pt)
|
2006-06-23 |
2013-01-15 |
Incyte Corp |
composto ou prà-droga ou sal farmaceuticamente aceitÁvel do mesmo, composiÇço, e, uso do composto.
|
WO2008001160A1
(en)
|
2006-06-23 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
ATE486874T1
(de)
|
2006-06-23 |
2010-11-15 |
Incyte Corp |
Purinonderivate als hm74a-agonisten
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
WO2008002575A1
(en)
|
2006-06-26 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
AU2007265457C1
(en)
|
2006-06-27 |
2012-11-29 |
Intercept Pharmaceuticals, Inc. |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
|
TW200815418A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds I
|
GEP20115359B
(en)
|
2006-06-27 |
2011-12-26 |
Takeda Pharmaceutical |
Fused cyclic compounds
|
CN101096363B
(zh)
|
2006-06-27 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
|
PE20080212A1
(es)
|
2006-06-27 |
2008-04-25 |
Sanofi Aventis |
Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1)
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
TW200815417A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds II
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
US20080004281A1
(en)
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
AU2007266078B2
(en)
|
2006-06-29 |
2011-12-15 |
Taisho Pharmaceutical Co., Ltd. |
C-phenyl 1-thioglucitol compound
|
WO2008002820A2
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted benzyl amine compounds
|
CN101511775A
(zh)
|
2006-06-29 |
2009-08-19 |
詹森药业有限公司 |
丁基和丁炔基苄基胺化合物
|
CN101479249B
(zh)
|
2006-06-29 |
2012-10-10 |
霍夫曼-拉罗奇有限公司 |
苯并咪唑衍生物、其制备方法、它们作为fxr激动剂的用途及含有它们的药物制剂
|
AU2007265240A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted aminomethyl benzamide compounds
|
US20080004325A1
(en)
|
2006-06-29 |
2008-01-03 |
Wyeth |
PTP1B inhibitors
|
WO2008005338A1
(en)
|
2006-06-29 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
|
CN101511807A
(zh)
|
2006-06-29 |
2009-08-19 |
詹森药业有限公司 |
组胺h3受体的取代的苯甲酰胺调节剂
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
BRPI0714200A2
(pt)
|
2006-07-05 |
2012-12-25 |
Hoffmann La Roche |
composto derivado de alquil-piridazina, processo para a sua preparaÇço, composiÇço farmacÊutica que compreende o mesmo, seu uso e mÉtodos para o tratamento e/ou profilaxia de enfermidades
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
WO2008005910A2
(en)
|
2006-07-06 |
2008-01-10 |
Bristol-Myers Squibb Company |
Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
US7888504B2
(en)
|
2006-07-06 |
2011-02-15 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
DE102006031176A1
(de)
|
2006-07-06 |
2008-01-10 |
Bayer Healthcare Ag |
Substituierte Benzoxepino-isoxazole und ihre Verwendung
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
JP5194588B2
(ja)
|
2006-07-06 |
2013-05-08 |
大正製薬株式会社 |
1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
|
US20080009534A1
(en)
|
2006-07-07 |
2008-01-10 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
CN101100458A
(zh)
|
2006-07-07 |
2008-01-09 |
上海艾力斯医药科技有限公司 |
具有PPARγ激动剂活性的双苯并咪唑衍生物及其应用
|
US7803799B2
(en)
|
2006-07-07 |
2010-09-28 |
National Health Research Institutes |
Selenophene compounds
|
US7795291B2
(en)
|
2006-07-07 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
|
FR2903404B1
(fr)
|
2006-07-10 |
2008-08-22 |
Servier Lab |
Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2008007211A1
(en)
|
2006-07-11 |
2008-01-17 |
Pfizer Japan Inc. |
Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
|
US7297710B1
(en)
|
2006-07-12 |
2007-11-20 |
Sanofi-Aventis |
Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics
|
EP2044073A1
(en)
|
2006-07-13 |
2009-04-08 |
High Point Pharmaceuticals, LLC |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
EP1878721A1
(en)
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JPWO2008007780A1
(ja)
|
2006-07-13 |
2009-12-10 |
協和発酵キリン株式会社 |
ペンタジエナミド誘導体
|
JP5372318B2
(ja)
|
2006-07-14 |
2013-12-18 |
パナソニック株式会社 |
電気化学キャパシタの製造方法
|
EP2049526A2
(en)
|
2006-07-14 |
2009-04-22 |
Merck & Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
ATE477252T1
(de)
|
2006-07-14 |
2010-08-15 |
Merck Sharp & Dohme |
Substituierte diazepane als antagonisten an orexinrezeptoren
|
WO2008008517A2
(en)
|
2006-07-14 |
2008-01-17 |
Merck & Co., Inc. |
Bridged diazepan orexin receptor antagonists
|
WO2008008547A2
(en)
|
2006-07-14 |
2008-01-17 |
Ams Research Corporation |
Balloon dilation for implantable prosthesis
|
TWI332501B
(en)
|
2006-07-14 |
2010-11-01 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
BRPI0714828A2
(pt)
|
2006-07-17 |
2013-04-09 |
Novartis Ag |
amidas de Ácido colÂnico
|
WO2008010061A2
(en)
|
2006-07-17 |
2008-01-24 |
Glenmark Pharmaceuticals S.A. |
3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
DE102006033140A1
(de)
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
AU2007275301A1
(en)
|
2006-07-20 |
2008-01-24 |
Amgen Inc. |
Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
|
US20090286790A1
(en)
|
2006-07-20 |
2009-11-19 |
Hidetomo Imase |
Organic compounds
|
AU2007274598A1
(en)
|
2006-07-21 |
2008-01-24 |
Lupin Limited |
Antidiabetic azabicyclo [3. 1. 0] hexan compounds
|
FR2903984B1
(fr)
|
2006-07-24 |
2008-10-03 |
Genfit Sa |
Derives d'imidazolones substitues, preparation et utilisations
|
US20100022589A1
(en)
|
2006-07-27 |
2010-01-28 |
Mccoull William |
Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
|
US20100009969A1
(en)
|
2006-07-27 |
2010-01-14 |
Ucb Pharma, S.A. |
Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
TWI403516B
(zh)
|
2006-07-27 |
2013-08-01 |
Chugai Pharmaceutical Co Ltd |
To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
|
TWI432446B
(zh)
|
2006-07-27 |
2014-04-01 |
Chugai Pharmaceutical Co Ltd |
稠環螺酮縮醇衍生物、及其做為糖尿病治療藥之使用
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
US20080027014A1
(en)
|
2006-07-28 |
2008-01-31 |
Tanabe Seiyaku Co., Ltd. |
Novel SGLT inhibitors
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
CN101511780A
(zh)
|
2006-08-02 |
2009-08-19 |
希格马托制药工业公司 |
作为cpt-抑制剂的4-三甲基铵-3-氨基丁酸盐和4-三甲基-3-氨基丁酸盐衍生物
|
WO2008016730A2
(en)
|
2006-08-02 |
2008-02-07 |
Targeted Molecular Diagnostics, Llc |
Compositions and methods for reducing cellular fat
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
MX2009001279A
(es)
|
2006-08-03 |
2009-02-11 |
Tufts College |
Analogos de niacina no eritematosos, y metodos para utilizar los mismos.
|
US7514433B2
(en)
|
2006-08-03 |
2009-04-07 |
Hoffmann-La Roche Inc. |
1H-indole-6-yl-piperazin-1-yl-methanone derivatives
|
WO2008016175A1
(fr)
|
2006-08-03 |
2008-02-07 |
Nippon Chemiphar Co., Ltd. |
Agent activant de récepteur activé par les proliférateurs des peroxysomes
|
WO2008019309A1
(en)
|
2006-08-04 |
2008-02-14 |
Metabasis Therapeutics, Inc. |
Novel inhibitors of fructose 1,6-bisphosphatase
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
EP2058309A4
(en)
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
KR100826108B1
(ko)
|
2006-08-04 |
2008-04-29 |
한국화학연구원 |
퓨란-2-카복실산 유도체 및 그의 제조 방법
|
EP2049520A4
(en)
|
2006-08-07 |
2011-01-05 |
Ironwood Pharmaceuticals Inc |
indole compounds
|
EP1887006A1
(en)
|
2006-08-07 |
2008-02-13 |
Krka |
Polymorphic forms of rosiglitazone base
|
WO2008017381A1
(de)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
|
US8071583B2
(en)
|
2006-08-08 |
2011-12-06 |
Boehringer Ingelheim International Gmbh |
Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus
|
WO2008021851A2
(en)
|
2006-08-09 |
2008-02-21 |
Smithkline Beecham Corporation |
Novel compounds as antagonists or inverse agonists for opioid receptors
|
US8633175B2
(en)
|
2006-08-09 |
2014-01-21 |
Glaxosmithkline Llc |
Compounds as antagonists or inverse agonists at opioid receptors
|
US7750019B2
(en)
|
2006-08-11 |
2010-07-06 |
Kowa Company, Ltd. |
Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
|
WO2008022015A2
(en)
|
2006-08-11 |
2008-02-21 |
Trustees Of Tufts College |
Retro-inverso incretin analogues, and methods of use thereof
|
WO2008017852A1
(en)
|
2006-08-11 |
2008-02-14 |
Palatin Technologies, Inc. |
Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators
|
TWI433839B
(zh)
|
2006-08-11 |
2014-04-11 |
Neomed Inst |
新穎的苯并咪唑衍生物290
|
US8039441B2
(en)
|
2006-08-15 |
2011-10-18 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as SGLT inhibitors and process for their manufacture
|
DE602007012910D1
(de)
|
2006-08-15 |
2011-04-14 |
Actelion Pharmaceuticals Ltd |
Azetidinverbindungen als orexin-rezeptor-antagonisten
|
JP2009256208A
(ja)
|
2006-08-17 |
2009-11-05 |
Dainippon Sumitomo Pharma Co Ltd |
フタリド誘導体またはその薬学的に許容される塩
|
EP2057188B1
(en)
|
2006-08-17 |
2013-07-31 |
Amylin Pharmaceuticals, LLC |
Dpp-iv resistant gip hybrid polypeptides with selectable properties
|
EP2054055A2
(en)
|
2006-08-18 |
2009-05-06 |
N.V. Organon |
Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
|
EP2056828A4
(en)
|
2006-08-21 |
2010-06-23 |
Merck Sharp & Dohme |
SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS
|
AU2007288198A1
(en)
|
2006-08-23 |
2008-02-28 |
Neurogen Corporation |
Haloalkyl-substituted pyrimidinone derivatives
|
US8003656B2
(en)
|
2006-08-23 |
2011-08-23 |
Neurogen Corporation |
2-phenoxy pyrimidinone analogues
|
AU2007287319A1
(en)
|
2006-08-23 |
2008-02-28 |
Pfizer Products Inc. |
Pyrimidone compounds as GSK-3 inhibitors
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US8927715B2
(en)
|
2006-08-25 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
WO2008026149A1
(en)
|
2006-08-28 |
2008-03-06 |
Actelion Pharmaceuticals Ltd |
1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists
|
EP1894928A1
(en)
|
2006-08-29 |
2008-03-05 |
PheneX Pharmaceuticals AG |
Heterocyclic fxr binding compounds
|
WO2008029217A2
(en)
|
2006-08-29 |
2008-03-13 |
Orchid Research Laboratories Limited |
Dipeptidyl peptidase iv inhibitors
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
EP2058305A4
(en)
|
2006-08-30 |
2010-09-22 |
Shionogi & Co |
UREA DERIVATIVE
|
CL2007002499A1
(es)
|
2006-08-30 |
2008-03-14 |
Phenomix Corp |
Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes.
|
JP5187901B2
(ja)
|
2006-08-30 |
2013-04-24 |
塩野義製薬株式会社 |
ヒドラジンアミド誘導体
|
WO2008025799A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyridazine compounds for treating gpr119 related disorders
|
US7470697B2
(en)
|
2006-09-01 |
2008-12-30 |
Adenosine Therapeutics, Llc |
Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptors
|
WO2008028188A2
(en)
|
2006-09-01 |
2008-03-06 |
The Ticket Reserve |
Demand aggregation for future items contingent upon threshold demand
|
NZ575346A
(en)
|
2006-09-01 |
2012-02-24 |
Vertex Pharma |
5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
|
US20080103122A1
(en)
|
2006-09-05 |
2008-05-01 |
Schering Corporation |
Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
|
JP2008063256A
(ja)
|
2006-09-06 |
2008-03-21 |
Astellas Pharma Inc |
β‐アミノ酸誘導体
|
WO2008031032A2
(en)
|
2006-09-07 |
2008-03-13 |
Transition Therapeutics Inc. |
Compounds for and methods of treating insulin resistance and inflammation
|
CA2662242C
(en)
|
2006-09-07 |
2012-06-12 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
WO2008028662A1
(en)
|
2006-09-07 |
2008-03-13 |
Santhera Pharmaceuticals (Schweiz) Ag |
N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus
|
AU2007293028B2
(en)
|
2006-09-07 |
2012-05-31 |
Amgen Inc. |
Heterocyclic GPR40 modulators
|
EP2068862A2
(en)
|
2006-09-08 |
2009-06-17 |
The Scripps Research Institute |
Substituted oxazole ketone modulators of fatty acid amide hydrolase
|
MX2009002527A
(es)
|
2006-09-08 |
2009-03-20 |
Pfizer Prod Inc |
Derivados de eter diarilico y usos de los mismos.
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
JP2010503654A
(ja)
|
2006-09-12 |
2010-02-04 |
ファイザー・プロダクツ・インク |
ベンゾイミダゾロン誘導体
|
WO2008032980A1
(en)
|
2006-09-12 |
2008-03-20 |
Cns Pharm Korea Co., Ltd. |
Novel stigmasterol derivative or pharmaceutically acceptable salt thereof, method of producing the same, and composition containing the same to inhibit obesity or to prevent and treat hyperlipidemia
|
WO2008033934A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
|
WO2008033931A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
|
PT2073810E
(pt)
|
2006-09-13 |
2011-09-30 |
Takeda Pharmaceutical |
Utilização de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo- 3,4-di-hidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo para tratamento de diabetes, cancro, distúrbios auto-imunes e infecção por vih
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
WO2008034032A2
(en)
|
2006-09-14 |
2008-03-20 |
Azevan Pharmaceuticals, Inc. |
Beta-lactam cannabinoid receptor modulators
|
US7781593B2
(en)
|
2006-09-14 |
2010-08-24 |
Hoffmann-La Roche Inc. |
5-phenyl-nicotinamide derivatives
|
US20080070890A1
(en)
|
2006-09-15 |
2008-03-20 |
Burnett Duane A |
Spirocyclic Azetidinone Compounds and Methods of Use Thereof
|
US20080076750A1
(en)
|
2006-09-15 |
2008-03-27 |
Aslanian Robert G |
Azetidinone Derivatives and Methods of Use Thereof
|
CN101583612A
(zh)
|
2006-09-15 |
2009-11-18 |
先灵公司 |
治疗脂质代谢障碍的氮杂环丁酮衍生物
|
EP2069302B1
(en)
|
2006-09-15 |
2010-08-25 |
Pfizer Inc. |
Substituted pyridylmethyl bicyclocarboxyamide compounds
|
KR101088239B1
(ko)
|
2006-09-20 |
2011-11-30 |
일라이 릴리 앤드 캄파니 |
Crf1 수용체 길항제로서의 티아졸 피라졸로피리미딘
|
WO2008036021A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands
|
US8110580B2
(en)
|
2006-09-20 |
2012-02-07 |
Eli Lilly And Company |
Thiophene pyrazolopyrimidine compounds
|
WO2008035356A2
(en)
|
2006-09-20 |
2008-03-27 |
Glenmark Pharmaceuticals Limited |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
WO2008036022A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands
|
CA2664095A1
(en)
|
2006-09-21 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
ES2601839T3
(es)
|
2006-09-22 |
2017-02-16 |
Novo Nordisk A/S |
Análogos de insulina resistentes a proteasas
|
AU2007300529A1
(en)
|
2006-09-27 |
2008-04-03 |
Merck Sharp & Dohme Corp. |
Acylated piperidine derivatives as melanocortin-4 receptor modulators
|
CN101528740B
(zh)
|
2006-09-29 |
2012-09-19 |
株式会社绿十字 |
作为大麻素cb1受体拮抗剂的杂芳基-吡唑衍生物
|
JP2010504957A
(ja)
|
2006-09-29 |
2010-02-18 |
アクテリオン ファーマシューティカルズ リミテッド |
3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
|
ES2357863T3
(es)
|
2006-09-29 |
2011-05-03 |
F. Hoffmann-La Roche Ag |
Derivados de la sulfonamida.
|
WO2008039882A1
(en)
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
RU2454405C2
(ru)
|
2006-10-04 |
2012-06-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
|
WO2008044656A1
(fr)
|
2006-10-06 |
2008-04-17 |
Taisho Pharmaceutical Co., Ltd. |
Dérivé d'imidazolidinone
|
PE20081152A1
(es)
|
2006-10-06 |
2008-08-10 |
Wyeth Corp |
Azaciclilaminas n-sustituidas como antagonistas de histamina-3
|
GB0619860D0
(en)
|
2006-10-06 |
2006-11-15 |
Birkeland Innovasjon As |
Treatment of insulin resistance and disorders associated therewith
|
AR063028A1
(es)
|
2006-10-06 |
2008-12-23 |
Banyu Pharma Co Ltd |
Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
|
WO2008040995A1
(en)
|
2006-10-07 |
2008-04-10 |
Peakdale Molecular Limited |
Indazoles for use as dpp-iv inhibitors
|
AU2007308154A1
(en)
|
2006-10-10 |
2008-04-17 |
Amgen Inc. |
N-aryl pyrazole compounds for use against diabetes
|
US20110039893A1
(en)
|
2006-10-11 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Gsk-3beta inhibitor
|
EP1911747A1
(en)
|
2006-10-11 |
2008-04-16 |
Laboratorios del Dr. Esteve S.A. |
Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
|
WO2008046071A2
(en)
|
2006-10-12 |
2008-04-17 |
Transition Therapeutics Inc. |
Compounds and methods of treating metabolic syndrome and inflammation
|
WO2008044111A1
(en)
|
2006-10-13 |
2008-04-17 |
Pfizer Products Inc. |
Pharmaceutical formulation tablet
|
BRPI0719523A2
(pt)
|
2006-10-13 |
2015-06-16 |
Chugai Pharmaceutical Co Ltd |
Derivado de espirocetal de tioglicose e uso deste como agente terapêutico para diabetes
|
US20080107725A1
(en)
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
CA2849697A1
(en)
|
2006-10-16 |
2008-04-24 |
Alexandros Eleftheriadis |
Systems and methods for signaling and performing temporal level switching in scalable video coding
|
DE102006048728A1
(de)
|
2006-10-16 |
2008-04-17 |
Merck Patent Gmbh |
3-Amino-imidazo{1,2-a]pyridinderivate
|
WO2008048648A2
(en)
|
2006-10-17 |
2008-04-24 |
Acadia Pharmaceuticals Inc. |
Cb1-modulating compounds and their use
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
EP2298772A1
(en)
|
2006-10-18 |
2011-03-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
RU2439062C2
(ru)
|
2006-10-19 |
2012-01-10 |
Ф.Хоффманн-Ля Рош Аг |
Производные имидазолона и имидазолидинона как 11в-hsd1 ингибиторы при диабете
|
ME00681B
(me)
|
2006-10-19 |
2011-12-20 |
Takeda Pharmaceuticals Co |
Jedinjenje indola
|
CA2666482A1
(en)
|
2006-10-20 |
2008-05-02 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
US20100204278A1
(en)
|
2006-10-20 |
2010-08-12 |
Beresis Richard T |
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
|
EP2081898A2
(en)
|
2006-10-20 |
2009-07-29 |
Arete Therapeutics, INC. |
Adamantylurea compounds as soluble epoxide hydrolase inhibitors
|
TW200825063A
(en)
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
KR100812538B1
(ko)
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
US8158650B2
(en)
|
2006-10-23 |
2012-04-17 |
Pfizer Inc. |
Substituted phenylmethyl bicyclocarboxyamide compounds
|
JO2653B1
(en)
|
2006-10-24 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Tetrahydroflavin 1-carboxylic acid substituted with pyridine or pyrazine inhibit MTB
|
KR101387459B1
(ko)
|
2006-10-24 |
2014-05-14 |
얀센 파마슈티카 엔.브이. |
Mtp를 저해하는 테트라하이드로-나프탈렌-1-카복실산 유도체
|
CL2007003061A1
(es)
|
2006-10-26 |
2008-08-01 |
Astrazeneca Ab |
Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
|
US20080103201A1
(en)
|
2006-10-26 |
2008-05-01 |
Wijayabandara Mirihanage Don J |
Novel alpha-Glucosidase inhibitor from Tabernaemontana dichotoma
|
EP2086991A1
(en)
|
2006-10-27 |
2009-08-12 |
Boehringer Ingelheim International GmbH |
CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
|
WO2008049711A1
(en)
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
CA2667249A1
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
EP2094692B1
(en)
|
2006-11-01 |
2012-11-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
CN101573356A
(zh)
|
2006-11-01 |
2009-11-04 |
百时美施贵宝公司 |
糖皮质激素受体、AP-1和/或NF-kB活性的调节剂及其用途
|
MX2009004336A
(es)
|
2006-11-01 |
2009-05-22 |
Pronova Biopharma Norge As |
Lipidos omega-3 alfa-sustituidos que son activadores o moduladores del receptor activado por proliferadores de peroxisoma (ppar).
|
EP2089355A2
(en)
|
2006-11-01 |
2009-08-19 |
Brystol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
|
US7994190B2
(en)
|
2006-11-01 |
2011-08-09 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
WO2008057857A1
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
|
NZ576750A
(en)
|
2006-11-02 |
2012-01-12 |
Vertex Pharma |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
EP1918281A1
(en)
|
2006-11-02 |
2008-05-07 |
Laboratorios del Dr. Esteve S.A. |
Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
|
CN101535249A
(zh)
|
2006-11-02 |
2009-09-16 |
塞诺菲-安万特德国有限公司 |
具有改善的药理性质的新的哌嗪-1-磺酸取代的二苯基氮杂环丁酮
|
US20100069347A1
(en)
|
2006-11-02 |
2010-03-18 |
Morriello Gregori J |
Heterocyclyl-substituted anti-hypercholesterolemic compounds
|
ATE528306T1
(de)
|
2006-11-02 |
2011-10-15 |
Piramal Life Sciences Ltd |
Benzoxazepin-verbindungen, ihre herstellung und verwendung
|
WO2008053341A2
(en)
|
2006-11-03 |
2008-05-08 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
EP1918285A1
(en)
|
2006-11-03 |
2008-05-07 |
Merck Sante |
Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
|
TW200827346A
(en)
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
WO2008056377A2
(en)
|
2006-11-06 |
2008-05-15 |
Cadila Healthcare Limited |
Polymorphic forms of rimonabant
|
EP2079753A1
(en)
|
2006-11-06 |
2009-07-22 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
|
EP1921080B1
(en)
|
2006-11-07 |
2009-08-05 |
Sanofi-Aventis |
Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives
|
EP3037095A3
(en)
|
2006-11-09 |
2016-11-16 |
Boehringer Ingelheim International GmbH |
Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
|
JP2010043001A
(ja)
|
2006-11-09 |
2010-02-25 |
Sanwa Kagaku Kenkyusho Co Ltd |
Glp−1誘導体とその用途
|
EP1921072A1
(en)
|
2006-11-10 |
2008-05-14 |
Laboratorios del Dr. Esteve S.A. |
1,2,3-Triazole derivatives as cannabinoid-receptor modulators
|
GB0622569D0
(en)
|
2006-11-11 |
2006-12-20 |
7Tm Pharma As |
Cannabinoid receptor modulators
|
KR20090064478A
(ko)
|
2006-11-13 |
2009-06-18 |
화이자 프로덕츠 인크. |
디아릴, 디피리디닐 및 아릴-피리디닐 유도체, 및 이들의 용도
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE102006053636B4
(de)
|
2006-11-14 |
2008-09-18 |
Sanofi-Aventis Deutschland Gmbh |
Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung
|
WO2008058631A1
(de)
|
2006-11-14 |
2008-05-22 |
Sanofi-Aventis Deutschland Gmbh |
Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
RU2009122504A
(ru)
|
2006-11-15 |
2010-12-20 |
Новартис АГ (CH) |
Гетероциклические производные в качестве ингибиторов белка сетр
|
WO2008058967A1
(en)
|
2006-11-15 |
2008-05-22 |
Novartis Ag |
Organic compounds
|
US7964732B2
(en)
|
2006-11-17 |
2011-06-21 |
Pfizer Inc. |
Substituted bicyclocarboxyamide compounds
|
US20100130435A1
(en)
|
2006-11-17 |
2010-05-27 |
National University Corporation Kagawa University |
Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
|
JP2010510317A
(ja)
|
2006-11-20 |
2010-04-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
ジペプチジルペプチダーゼivの阻害剤としての7,8−ジヒドロ−1,6−ナフチリジン−5(6h)−オンおよび関連二環式化合物、および方法
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
AU2007334519A1
(en)
|
2006-12-14 |
2008-06-26 |
Merck Sharp & Dohme Corp. |
Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|